azd8848
Small moleculeexperimental
Clinical trial activity
9 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
7
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2008 (NCT00688779)
Timeline
Indications
Mechanism of action
- Toll-like receptor 7AGONIST
TLR7 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- azd8848
- azd8848
- dsp-3025
- dsp-3025
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01818869 | Phase 1 | Jan 1, 2014 | AstraZeneca, IQVIA |
| NCT01560234 | Phase 1 | May 1, 2012 | AstraZeneca, IQVIA |
| NCT01203124 | Phase 1 | Nov 1, 2010 | AstraZeneca, IQVIA |
| NCT01185080 | Phase 2 | Sep 1, 2010 | AstraZeneca, Lund University |
| NCT01205867 | Phase 1 | Sep 1, 2010 | AstraZeneca, DanTrials ApS, Copenhagen, Denmark |
| NCT00999466 | Phase 2 | Oct 1, 2009 | AstraZeneca |
| NCT00925678 | Phase 1 | Jun 1, 2009 | Sumitomo Dainippon |
| NCT00770003 | Phase 1 | Sep 1, 2008 | AstraZeneca, Lund University |
| NCT00688779 | Phase 1 | Jan 1, 2008 | AstraZeneca, Lund University |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AstraZeneca | For profit | 8 | 8 | 2 | 2008 |
| IQVIA | For profit | 3 | 0 | 1 | 2010 |
| Lund University | Academic/Hospital | 3 | 0 | 2 | 2008 |
| DanTrials ApS, Copenhagen, Denmark | For profit | 1 | 0 | 1 | 2010 |
| Sumitomo Dainippon | For profit | 1 | 1 | 1 | 2009 |
5 organizations
Page 1 / 1